Maternal Demographic Patterns in Medication use During Pregnancy: A Nationwide Register Study

IF 3.3 4区 医学 Q2 PHARMACOLOGY & PHARMACY Basic & Clinical Pharmacology & Toxicology Pub Date : 2025-03-18 DOI:10.1111/bcpt.70020
Mette Østergaard Thunbo, Julie Hauer Vendelbo, Daniel R. Witte, Agnete Larsen, Lars Henning Pedersen
{"title":"Maternal Demographic Patterns in Medication use During Pregnancy: A Nationwide Register Study","authors":"Mette Østergaard Thunbo,&nbsp;Julie Hauer Vendelbo,&nbsp;Daniel R. Witte,&nbsp;Agnete Larsen,&nbsp;Lars Henning Pedersen","doi":"10.1111/bcpt.70020","DOIUrl":null,"url":null,"abstract":"<p>In recent years, medication use during pregnancy has increased, yet its association with maternal characteristics remains unclear. To address this gap, we aimed to investigate how maternal age, pre-gestational body mass index (BMI), smoking, parity, ethnic origin and employment status relate to medication use during pregnancy. We conducted a nationwide Danish registry study, including 698 447 clinically recognised pregnancies with a gestational age of at least 10 weeks, spanning from 2008 to 2018. Medication use was estimated based on prescription redemptions during pregnancy and stratified by the demographic factors of interest. Overall, 60.3% of pregnant women redeemed at least one prescription, while 28.9% redeemed multiple medications. Notably, higher usage was observed among women aged 35 or older, those with a BMI of 30 kg/m<sup>2</sup> or more, smokers, multipara, Black women, and early retirees. Medication combination patterns differed with the demographic subgroups. These findings highlight notable differences in medication use among demographic groups during pregnancy, underscoring the need for tailored healthcare strategies during pregnancy.</p>","PeriodicalId":8733,"journal":{"name":"Basic & Clinical Pharmacology & Toxicology","volume":"136 4","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bcpt.70020","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic & Clinical Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.70020","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

In recent years, medication use during pregnancy has increased, yet its association with maternal characteristics remains unclear. To address this gap, we aimed to investigate how maternal age, pre-gestational body mass index (BMI), smoking, parity, ethnic origin and employment status relate to medication use during pregnancy. We conducted a nationwide Danish registry study, including 698 447 clinically recognised pregnancies with a gestational age of at least 10 weeks, spanning from 2008 to 2018. Medication use was estimated based on prescription redemptions during pregnancy and stratified by the demographic factors of interest. Overall, 60.3% of pregnant women redeemed at least one prescription, while 28.9% redeemed multiple medications. Notably, higher usage was observed among women aged 35 or older, those with a BMI of 30 kg/m2 or more, smokers, multipara, Black women, and early retirees. Medication combination patterns differed with the demographic subgroups. These findings highlight notable differences in medication use among demographic groups during pregnancy, underscoring the need for tailored healthcare strategies during pregnancy.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
怀孕期间药物使用的孕产妇人口统计模式:一项全国登记研究
近年来,怀孕期间的药物使用有所增加,但其与产妇特征的关系尚不清楚。为了解决这一差距,我们旨在调查产妇年龄、孕前体重指数(BMI)、吸烟、胎次、种族血统和就业状况与妊娠期间药物使用的关系。我们进行了一项全国范围的丹麦登记研究,包括2008年至2018年期间临床认可的胎龄至少为10周的698447例妊娠。药物使用是根据怀孕期间的处方赎回来估计的,并根据感兴趣的人口统计学因素进行分层。总体而言,60.3%的孕妇至少使用了一种药物,而28.9%的孕妇使用了多种药物。值得注意的是,35岁及以上的女性、体重指数为30 kg/m2或以上的女性、吸烟者、多配偶、黑人女性和提前退休人员的使用率较高。药物组合模式因人口亚组而异。这些发现突出了怀孕期间不同人口统计学群体在药物使用方面的显著差异,强调了怀孕期间量身定制医疗保健策略的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.60
自引率
6.50%
发文量
126
审稿时长
1 months
期刊介绍: Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.
期刊最新文献
Isorhamnetin Protects Against Organophosphate-Induced Cardiac Damage in Wistar Rats Through Redox Balance and Nrf2/HO-1 Signalling. Patients' Attitudes Towards Deprescribing and Associations With Patient-Related Factors Across Two Hospital Settings. Patients' Perspectives on Antidepressant Discontinuation and the Pharmacists' Role. Vericiguat as a Novel Ferroptosis Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity. Supporting General Practitioners to Deprescribe Benzodiazepines and Z-Drugs in Primary Care: Findings From a Modified Delphi Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1